Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Tvardi Therapeutics
(69C.F) Q2 2025
Earnings
69C.F
May 13
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-6.49
-4.4
-2.31
-0.23
Details
Expected EPS
-0.52277355
Actual EPS
-2.8774886000000004
Surprise EPS
-2.35
Surprise Percent
-450.43%
Description
Tvardi Therapeutics (69C.F) has reported earnings of -2.8774886000000004 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login